Conquering Diseases

Remdesivir For The Treatment Of Sars-Cov2 (Cov) Infection


An investigational drug treatment for patients who have been hospitalized with the coronavirus COVID-19; University Campus


The primary objective of this study is to provide expanded access of remdesivir (RDV) for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV2) infection.

What we're hoping for

We are hoping that the experimental drug is safe for use and helps people hospitalized with the COVID-19 coronavirus recover.

Additional Information Identifier: NCT04323761

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

Jaclyn  Longtine



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655